Clinical Trials

17 enrolled

Lymphoma, B-Cell

NCT05487651 2023-05-18

ANCHOR2

LymphoidOther hematologic neoplasmSarcoma

36 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT04887025 2023-02-06

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

25 enrolled

Recurrence, Lymphoma, B-Cell

NCT05585996 2023-02-06

Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma

70 enrolled

Recurrence, Lymphoma, B-Cell

NCT04684472 2022-09-26

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

18 enrolled

Leukemia, Lymphoma, B-Cell

NCT05453669 2022-07-12

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

12 enrolled

Lymphoma, B-Cell

NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

24 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT05003141 2022-03-28

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

110 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT04289220 2021-05-13

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04814004 2021-03-29

Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04796688 2021-03-15

Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies

27 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04204161 2021-02-04

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

30 enrolled

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04296461 2021-01-22

Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT03559439 2020-11-05

CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies

9 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

50 enrolled

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT04173455 2019-11-22

Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma

46 enrolled

Lymphoma, B-Cell

NCT04056975 2019-08-14

A-319

54 enrolled

Recurrence, Lymphoma, B-Cell

NCT04007978 2019-08-07

Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies

50 enrolled

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04008251 2019-08-07

Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03999697 2019-06-27

A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies

LymphoidPlasma cell

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

NCT03881761 2019-03-21

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

50 enrolled

Recurrence, Lymphoma, B-Cell

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03854994 2019-02-26

CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma, Lymphoma, B-Cell

NCT02842138 2019-02-25

Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma

25 enrolled

Lymphoma, B-Cell

NCT03060850 2019-02-01

A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

184 enrolled

Lymphoma, B-Cell

NCT03685786 2018-12-07

CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT03576807 2018-07-03

The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03383952 2017-12-27

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03299738 2017-12-19

A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL

Lymphoma, B-Cell

NCT03208556 2017-09-14

Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma